Structure–activity relationships of adenosine A3 receptor ligands: new potential therapy for the treatment of glaucoma
Structure–activity relationships (SAR) of fused 1,2,4-triazolo[1,5-c]pyrimidines (1, 2, and 3) were performed.
Section snippets
Acknowledgments
We thank Dr. Yasuhide Inoue, Dr. Akira Momii, Mr. Hiroshi Fujiwara, and Mr. Eric Hasegawa (Otsuka Pharmaceutical Factory, Inc.) for their support of this effort.
References (12)
- et al.
Bioorg. Med. Chem.
(2004) - et al.
Drugs Today
(2002) Expert Opin. Drug Saf.
(2002)- et al.
Am. J. Physiol.
(1999) - et al.
Invest. Ophthalmol. Vis. Sci.
(2002) - et al.
J. Med. Chem.
(1996)
There are more references available in the full text version of this article.
Cited by (0)
- 1
Present address: Cambridge Isotope Laboratories, 50 Frontage Road, Andover, MA 01810, USA.
Copyright © 2004 Elsevier Ltd. All rights reserved.